Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: Medochemie Ltd, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Snip tablets.
| Pharmaceutical Form |
|---|
|
White, round, flat, scored tablets embossed Snip. The score line is not intended for breaking the tablet. |
Each tablet contains 325mg paracetamol, 15mg pseudoephedrine hydrochloride and 1mg clorpheniramine maleate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Chlorphenamine |
Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity. |
|
| Paracetamol |
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
|
| Pseudoephedrine |
Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
Packs containing 10, 20 and 30 tablets in PVC/Alu blisters are available.
Medochemie Ltd, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
20113
Date of first authorisation: 22/06/2006
Date of first renewal of authorisation: 11/02/2015
| Drug | Countries | |
|---|---|---|
| SNIP | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
